XOSPATA
Identification of Xospata
| No description |
Google image searchProduct monograph
Active ingredient
gilteritinib (gilteritinib fumarate), 40 MG
DIN: 02495058
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: ASTELLAS PHARMA CANADA INC
Date: 03-FEB-2020
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EX — Other protein kinase inhibitors (ATC, ATC/DDD)
- L01EX13 — GILTERITINIB (ATC/DDD)
Reference brand drug: Xospata
